Hypercalcaemia: From 4 Different Sources
Presence of abnormally high concentration of calcium in the blood. In infants, may follow too much Vitamin D in dried milk, with mental consequences. Also found in malignancy with bone metastases and parathyroid tumour.
Symptoms: Vomiting, loss of appetite, large volume of urine, constipation, intense thirst, extreme exhaustion, debilitating sweats. Regarded as a medical emergency for which phosphates, oral and rectal may be given.
Treatment. Plant medicines to lower calcium levels. Nettle tea.
HYPERCHLORHYDRIA. Secretion of too much hydrochloric acid in the stomach which prepares the mucosa for gastric ulcer. Treatment as for gastric ulcer.
An abnormally high level of calcium in the blood, commonly caused by hyperparathyroidism. Cancer may also cause hypercalcaemia, either by spreading to bone or producing abnormal hormones that cause bones to release calcium. Less commonly, the condition is a result of excessive intake of vitamin D or of certain inflammatory disorders, such as sarcoidosis.
Hypercalcaemia causes nausea, vomiting, lethargy, depression, thirst, and passing urine excessively.
Higher blood levels of calcium produce confusion, extreme fatigue, and muscle weakness.
Without treatment, the condition can result in cardiac arrhythmias, kidney failure, coma, and even death.
Long-standing hypercalcaemia may cause nephrocalcinosis or kidney stones (see calculus, urinary tract).
Diagnosis is by blood tests.
Treatment is of the underlying cause.
A state in which the PLASMA calcium concentration is signi?cantly raised. The most important causes are HYPERPARATHYROIDISM, malignant bone disease and other (non-metastatic) cancers, and chronic renal failure. Less common causes include SARCOIDOSIS, MYELOMATOSIS, vitamin D overdosage (see APPENDIX 5: VITAMINS), hyperthyroidism (see THYROID GLAND, DISEASES OF), and immobilisation.
Signs and symptoms A general malaise and depression are common, with generalised muscular weakness, anorexia and vomiting. Disturbed renal function causes increased urine output and thirst, with calcium deposits eventually leading to renal stones. Primary bone disease may cause pain and weakness, with an increased incidence of fractures, and there may be gritty deposits of calcium in the eyes. Severe hypercalcaemia produces ANURIA, with confusion and COMA leading to death.
Treatment The patient should be rehydrated and a diuretic (see DIURETICS) given. Attention should then be focused on the underlying cause – usually a parathyroid adenoma or bone tumour – and surgical removal should produce complete clinical cure, provided that advanced renal disease is not already present.
n. the presence in the blood of an abnormally high concentration of calcium. There are many causes, including excessive ingestion of vitamin D, overactivity of the *parathyroid glands, and malignant disease. Malignant hypercalcaemia results from the secretion by the tumour of substances (most commonly *parathyroid hormone-related protein) that stimulate bone resorption or from bone metastases causing localized destruction and release of calcium into the bloodstream. Hypercalcaemia may also occur as an inherited congenital condition, for example familial benign (or hypocalciuric) hypercalcaemia or *Williams syndrome. Compare hypocalcaemia.
A hormone, produced by the THYROID GLAND, which is involved in the metabolism of bone. Acting to lower concentrations of CALCIUM and PHOSPHATES in the blood, calcitonin is given by injection in the treatment of some patients with HYPERCALCAEMIA (especially when associated with malignant disease). In severe cases of PAGET’S DISEASE OF BONE it is used mainly for pain relief, but also relieves some of the neurological complications such as deafness.... calcitonin
An abnormally large amount of calcium in the urine. It is the most common single cause of stones in the KIDNEYS in Britain. (See HYPERCALCAEMIA.)... hypercalciuria
A rare type of hypercalcaemia accompanied by alkalosis and kidney failure. The syndrome is due to excessive, long-term intake of calciumcontaining antacid drugs and milk. It is most common in people with a peptic ulcer and associated kidney disorders. Symptoms include weakness, muscle pains, irritability, and apathy. Treatment is to reduce milk and antacid intake.... milk–alkali syndrome
pl. n. a class of drugs that inhibit the resorption of bone by blocking the action of *osteoclasts. This property makes them useful for treating certain bone disorders, such as Paget’s disease and osteoporosis, as well as malignant disease – both in terms of pain relief and in treating hypercalcaemia due to cancer. There is a risk of *osteonecrosis of the jaw in patients receiving bisphosphonates for cancer. This risk is increased by tooth extraction. Bisphosphonates include *alendronic acid, etidronate, *pamidronate disodium, risedronate, clodronate, and *zoledronic acid.... bisphosphonates
n. a drug that mimics the action of calcium in the body by activating the calcium-sensing cell receptors and thus reduces the level of *parathyroid hormone. It is used in the treatment of secondary *hyperparathyroidism in advanced kidney failure and also for reducing the level of *hypercalcaemia in parathyroid carcinoma. It is taken orally. Trade name: Mimpara.... cinacalcet
the calcification of injured or necrotic tissue in the absence of systemic *hypercalcaemia. Dystrophic calcification is a characteristic feature in some cancers of the breast, ovary, and thyroid gland. Compare metastatic calcification.... dystrophic calcification
defects of kidney function related to a high serum calcium, irrespective of cause. Impaired urine-concentrating ability and reduction in glomerular filtration rate are common features. Histologically, calcific deposits in the kidneys (*nephrocalcinosis) may be seen in cases of long-standing hypercalcaemia.... hypercalcaemic nephropathy
n. the presence in the blood of an abnormally low concentration of calcium. See tetany. Compare hypercalcaemia.... hypocalcaemia
disease of the *tubulointerstitium of the kidney. Acute interstitial nephritis (AIN) represents in many cases an allergic reaction to drugs (especially ampicillin, cephalexin, NSAIDs, allopurinol, and frusemide). AIN can also be associated with acute infections and autoimmune disease. Thirst and polyuria may be prominent, and renal function severely affected. In allergic cases, the use of steroids hastens recovery after the allergen has been removed. Chronic interstitial nephritis (CIN) is associated with progressive scarring of the tubulointerstitium, often with lymphocyte infiltration. Primary causes of CIN include gout, radiation nephropathy, sarcoidosis, *analgesic nephropathy, reflux nephropathy, chronic hypokalaemia and hypercalcaemia, and *Aristolochia-associated nephropathies. Management of CIN involves removal of the precipitating cause, where identified, and control of hypertension.... interstitial nephritis
the calcification of otherwise normal tissues in patients with *hypercalcaemia. Compare dystrophic calcification.... metastatic calcification
a *bisphosphonate drug used to treat malignant *hypercalcaemia, breast cancer that has spread to the bones, and Paget’s disease. Side-effects include flulike symptoms, nausea, and vomiting.... pamidronate disodium
(PTH-RP) a protein that is secreted by certain malignant tumours and is the main cause of malignant *hypercalcaemia. PTH-RP, which has effects similar to *parathyroid hormone, stimulates generalized bone resorption and excessive calcium reabsorption in the kidney tubules. It is most commonly produced by lung tumours, squamous-cell carcinomas of other organs, melanomas, and tumours of the breast, liver, pancreas, bladder, and prostate.... parathyroid hormone-related protein
n. a drug used in the treatment of *breast cancer: it binds with hormone receptors in the tumour to inhibit the effect of oestrogens (see anti-oestrogen; selective (o)estrogen receptor modulator). Tamoxifen is also used to treat female infertility as it induces ovulation. Side-effects include nausea, vaginal bleeding, facial flushing, tumour pain, and hypercalcaemia.... tamoxifen
(NDI) a condition characterized by *polyuria and *polydipsia and due to failure of the renal tubules to respond, or to respond fully, to *vasopressin. One form of congenital NDI is caused by an X-linked (see sex-linked) dominant mutation of the gene encoding the vasopressin V2 receptor. A rarer form of congenital NDI is an autosomal recessive condition associated with genetic mutations in the gene encoding AQP-2 water channels (see aquaporin). Acquired NDI is much commoner than the congenital form and usually less severe. It is present in most patients with advancing chronic renal failure, is a feature of certain electrolyte disorders (hypokalaemia, hypercalcaemia), and can complicate chronic lithium treatment.... nephrogenic diabetes insipidus
a hereditary condition, caused by a defect (a *deletion) in chromosome 7, marked by a characteristic ‘elfin’ facial appearance (including large eyes, a wide mouth, and small chin), *hypercalcaemia, short stature, learning disabilities, and *aortic stenosis. Most affected children are highly sociable and have unusual conversational ability, using a rich and complex vocabulary. The condition can be diagnosed prenatally. [J. C. P. Williams (20th century), British physician]... williams syndrome
(zolendronate) a *bisphosphonate drug that is used to treat Paget’s disease and malignant *hypercalcaemia and is also establishing a role in treating bone metastases, both in terms of symptom relief and preventing bone fractures.... zoledronic acid